What COVID Boosters Do to the Immune System

What COVID Boosters Do to the Immune System

Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital in Philadelphia and a longtime defender of mass vaccinations has now admitted that the Biden Administration overlooked a critical scientific reality. “There’s every reason to believe natural infection would prevent against serious disease and data has come out showing this was true.” Yet, when COVID-19 vaccine mandates swept across the nation, natural infection wasn’t even considered as an alternative.

Natural Immunity in People Sacrificed for Logistics

Offit attended meetings in early 2021 where the Biden Administration decided to lean into a strict pro-mandate police, ignoring the millions of Americans who had already recovered from COVID-19. Why? According to Offit, the administration didn’t want to deal with the logistics of verifying prior infection. Instead of working to verify legitimate cases of natural immunity, the government steamrolled ahead, demanding total vaccine compliance and punishing those who resisted. Frontline workers were fired despite having robust immunity from prior infection. Vaccine mandates divided society, creating a second-class citizenry of the “unvaccinated,” many of whom had already recovered from COVID-19 and posed little risk.

Scientists and medical professionals (me too!) who pointed to natural immunity were censored, deplatformed, or discredited, even as mounting evidence supported their claims. The most disturbing thing about it—it wasn’t a mistake—it was intentional. Instead of following the science, the administration followed the path of least resistance, sacrificing real people in the process. By 2021, multiple studies already showed that natural immunity was as strong—if not stronger—than vaccine-induced immunity. Yet, the U.S. government chose to ignore these findings and retaliated against anyone who challenged the political narrative. Millions of Americans lost jobs, medical autonomy, and fundamental rights because the government didn’t want to “add another layer” to their paperwork. Offit’s confession should be head-line news, but expert scientists and the adoring news media are not likely to draw attention to their mistakes.

What About COVID Boosters?

If you got multiple COVID-19 booster shots, something happened to your immune system that your doctor probably never mentioned, and that your post-vaccination blood test almost certainly cannot detect. A growing body of peer-reviewed research published between 2023 and 2025 documents that repeated mRNA boosting causes a progressive shift in the type of antibody your immune system produces against the virus. This shift is not random noise. It follows a well-understood biological pattern. And it has measurable, functional consequences.

An article by Dr. Robert W. Malone, explains what that shift is, what it means, who it matters most for, and what should be done about it. I’ve included a few excerpts below:

Not All Antibodies Are the Same

Your body makes several types of antibodies, labeled IgG1 through IgG4. When you encounter a virus or receive a vaccine for the first time, your immune system mostly produces IgG1 and IgG3. These are your fighter antibodies. They do two key things:

• They block the virus from entering your cells (this is called neutralization).

• They recruit other immune cells to find and destroy cells the virus has already infected. This second function is called ADCC (antibody-dependent cellular cytotoxicity), and it depends on a part of the antibody called the Fc region.

IgG4 is different. It is sometimes called the tolerance antibody. In normal life it appears in small amounts, mostly in situations where your immune system has been exposed to something repeatedly and decided it is not a threat, like bee venom in beekeepers or allergens in people completing immunotherapy. IgG4 can neutralize a virus, but it cannot perform ADCC, activate complement (another arm of the immune defense), or engage immune cell receptors that recruit other defenders to clear an infected cell.

In other words, IgG4 is a blocking antibody. It recognizes the virus and gets in the way, but it does not tell the rest of the immune system to attack.

IgG4 neutralizes the virus. It does not clear infected cells, activate complement, or recruit immune effectors. These are not equivalent things.

What Repeated Boosting Does to That Balance

After your first two COVID vaccines, your immune system produces mostly IgG1 and IgG3. The same is true after natural infection. That is the normal, expected response.

But something changes after a third dose, and in some case after the second dose, and becomes more pronounced with each additional dose. Multiple peer-reviewed studies now document that repeated mRNA boosting drives a progressive shift toward IgG4 in the antibody response specifically targeting the spike protein. In 2025, 31 million Americans (8.9%) got a COVID-19 booster. They didn’t realize that this shift:

• Is not seen after natural infection alone.

• Is not seen after adenoviral vector vaccines (like AstraZeneca or Johnson & Johnson).

• Is more pronounced with the Pfizer vaccine than with Moderna.

• Has been documented in children as young as 5 after only two pediatric doses.

A 2025 study (Kalkeri et al., Journal of Infectious Diseases) provided the first direct functional evidence of what this switch costs. Researchers found that higher IgG4 levels were negatively correlated with the ability to neutralize the virus and with all three measured immune effector functions (the cellular and molecular processes that clear infected cells). People who had received mRNA vaccines had IgG4 levels more than 150 times higher than those who had received a protein-subunit vaccine.

A separate 2025 study (Martín Pérez et al., Journal of Infection) found that healthcare workers who developed this IgG4 shift were more likely to get subsequent COVID-19 infections. This is the first published study to associate the IgG4 switch with a real-world adverse health outcome.

Why Repeated Boosting Causes This Shift

Your immune system learns from repetition. When it encounters the same antigen (in this case, the spike protein) over and over in a relatively calm context, it gradually classifies that antigen as a persistent, but non-threatening presence and shifts its response toward tolerance rather than attack. This is actually a useful feature in normal life. It is the same mechanism that lets beekeepers stop reacting to bee stings and lets allergy immunotherapy work.

The shift is driven by a molecule called IL-10, a chemical signal produced inside lymph nodes during the immune response. IL-10 acts locally, in the germinal centers where new antibodies are designed and refined. When IL-10 is present in those local environments, immune cells are steered toward producing IgG4 instead of IgG1 or IgG3.

The Memory Problem

Once IgG4-producing immune cells are created in germinal centers, they take up permanent residence in bone marrow as long-lived plasma cells. They continue producing IgG4 for years. They cannot be turned off by waiting, and they are not reversed by stopping vaccination. Every subsequent encounter with the spike protein (or other antigens that have elicited similar responses in specific lymph nodes), whether from a booster or from an actual infection, triggers these cells to produce more IgG4.

Additionally, a 2024 review (Kim, Immune Networks) synthesized evidence that the mRNA-LNP vaccine platform creates unusually prolonged immune reactions in lymph nodes, lasting six months or more. This extended activity enables each booster to further engrave the IgG4 pattern into memory. The same property that makes mRNA vaccines immunologically powerful also makes them structurally prone to this effect when given frequently.

Why Booster Spacing Matters

When boosters are given before the immune response to the previous dose has fully resolved, the signals overlap and amplify each other. This process is referred to as signal stacking. Each overlapping dose reinforces the IL-10 regulatory environment and pushes the IgG4 shift further. Boosters given at least a year apart allow the immune response to fully resolve and reset before re-exposure, reducing the probability of the IgG4 shift.

Risks of COVID-19 Boosting

1. Increased risk of breakthrough COVID infection

2. Loss of the immune functions that clear infected cells

3. The damage is written into immune memory

4. Impaired cancer immune surveillance.  The immune system kills early cancer cells partly through ADCC. If ADCC capacity is reduced, the body’s ability to catch and eliminate abnormal cells before they become tumors may be reduced.

5. Interference with cancer treatments.  High circulating IgG4 may compete with therapeutic antibodies for the Fc receptor sites on immune cells, potentially blunting the effectiveness of ADCC-dependent cancer drugs in patients who received boosters during treatment.

6. Weakened response to other vaccines and infections.  The regulatory B cells expanded by repeated boosting also suppress immune responses more broadly. Whether this reduces the effectiveness of flu shots, pneumonia vaccines, or other routine immunizations given at the same time has not been studied.